Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082888
Status:
COMPLETED
Last Update Posted:
2020-04-13
First Post:
2004-05-14
Brief Title:
Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI